These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22507127)

  • 1. Regulation and cellular functions of class II phosphoinositide 3-kinases.
    Falasca M; Maffucci T
    Biochem J; 2012 May; 443(3):587-601. PubMed ID: 22507127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into the intracellular roles of class II phosphoinositide 3-kinases.
    Maffucci T; Falasca M
    Biochem Soc Trans; 2014 Oct; 42(5):1378-82. PubMed ID: 25233418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II PI3K Functions in Cell Biology and Disease.
    Gulluni F; De Santis MC; Margaria JP; Martini M; Hirsch E
    Trends Cell Biol; 2019 Apr; 29(4):339-359. PubMed ID: 30691999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking.
    Yoshioka K
    Biochem Soc Trans; 2021 Apr; 49(2):893-901. PubMed ID: 33666217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 3-kinases in platelets, thrombosis and therapeutics.
    Ribes A; Oprescu A; Viaud J; Hnia K; Chicanne G; Xuereb JM; Severin S; Gratacap MP; Payrastre B
    Biochem J; 2020 Nov; 477(22):4327-4342. PubMed ID: 33242335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Class II Phosphoinositide 3-Kinases.
    Heng EYZ; Maffucci T
    Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II phosphoinositide 3-kinase C2alpha: what we learned so far.
    Mazza S; Maffucci T
    Int J Biochem Mol Biol; 2011; 2(2):168-182. PubMed ID: 21968800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.
    Tibolla G; Piñeiro R; Chiozzotto D; Mavrommati I; Wheeler AP; Norata GD; Catapano AL; Maffucci T; Falasca M
    PLoS One; 2013; 8(1):e53808. PubMed ID: 23320105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
    Mavrommati I; Cisse O; Falasca M; Maffucci T
    Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence from bioinformatics, expression and inhibition studies of phosphoinositide-3 kinase signalling in Giardia intestinalis.
    Cox SS; van der Giezen M; Tarr SJ; Crompton MR; Tovar J
    BMC Microbiol; 2006 May; 6():45. PubMed ID: 16707026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
    Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
    Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of first lead structures for phosphoinositide 3-kinase-C2γ inhibitors.
    Freitag A; Prajwal P; Shymanets A; Harteneck C; Nürnberg B; Schächtele C; Kubbutat M; Totzke F; Laufer SA
    J Med Chem; 2015 Jan; 58(1):212-21. PubMed ID: 24983663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis.
    Devereaux K; Dall'Armi C; Alcazar-Roman A; Ogasawara Y; Zhou X; Wang F; Yamamoto A; De Camilli P; Di Paolo G
    PLoS One; 2013; 8(10):e76405. PubMed ID: 24098492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II Phosphoinositide 3-Kinases as Novel Drug Targets.
    Falasca M; Hamilton JR; Selvadurai M; Sundaram K; Adamska A; Thompson PE
    J Med Chem; 2017 Jan; 60(1):47-65. PubMed ID: 27644332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module.
    Wang H; Lo WT; Vujičić Žagar A; Gulluni F; Lehmann M; Scapozza L; Haucke V; Vadas O
    Mol Cell; 2018 Jul; 71(2):343-351.e4. PubMed ID: 30029007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined deficiency of PI3KC2α and PI3KC2β reveals a nonredundant role for PI3KC2α in regulating mouse platelet structure and thrombus stability.
    Petitjean C; Setiabakti NM; Mountford JK; Arthur JF; Ellis S; Hamilton JR
    Platelets; 2016 Jul; 27(5):402-9. PubMed ID: 26943229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase: friend and foe in cardiovascular disease.
    Ghigo A; Li M
    Front Pharmacol; 2015; 6():169. PubMed ID: 26321955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
    Chikh A; Ferro R; Abbott JJ; Piñeiro R; Buus R; Iezzi M; Ricci F; Bergamaschi D; Ostano P; Chiorino G; Lattanzio R; Broggini M; Piantelli M; Maffucci T; Falasca M
    Oncotarget; 2016 Apr; 7(14):18325-45. PubMed ID: 26934321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice.
    Islam S; Yoshioka K; Aki S; Ishimaru K; Yamada H; Takuwa N; Takuwa Y
    J Physiol Sci; 2020 Mar; 70(1):18. PubMed ID: 32192434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.